临床肿瘤学杂志

• 论著 • 上一篇    下一篇

shRNA靶向沉默Eag 1钾通道对骨肉瘤细胞增殖、细胞周期及cyclin D1/E表达的影响

陈志达,戴立林,吴采荣,曾文容,熊远飞,吴进   

  1. 363000 福建漳州 厦门大学附属东南医院骨科
  • 收稿日期:2016-05-31 修回日期:2016-09-03 出版日期:2016-10-30 发布日期:2016-10-30
  • 通讯作者: 吴进

Effects of shRNA mediated Eag1 potassium channel silencing on cell proliferation, cell cycle and expression of cyclin D1/E in osteosarcoma cells

CHEN Zhida,DAI Lilin,WU Cairong,ZENG Wenrong,XIONG Yuanfei,WU Jin   

  1. Department of Orthopaedics,Affiliated Southeast Hospital of Xiamen University,Zhangzhou 363000,China
  • Received:2016-05-31 Revised:2016-09-03 Online:2016-10-30 Published:2016-10-30
  • Contact: WU Jin

摘要:

目的 探讨短发夹RNA(shRNA)靶向沉默Ether-go-go 1(Eag1)钾通道对骨肉瘤MG-63细胞增殖、细胞周期及cyclin D1/E表达的影响。 方法 使用成功构建的Ad5-Eag1-shRNA表达载体转染MG-63细胞(抑制组),同时设转染无义序列(Ad5-Control-shRNA)的空转染组及不进行任何处理的对照组。采用逆转录聚合酶链式反应和Western blotting检测Ad5-Eag1-shRNA转染骨肉瘤MG-63细胞后的Eag1 mRNA和蛋白水平,分别采用CCK-8法和克隆形成实验检测各组的细胞增殖情况,流式细胞仪和Western blotting分别检测各组的细胞周期变化和细胞周期蛋白(cyclin D1和cyclin E)的蛋白水平。建立裸鼠骨肉瘤异种移植模型并测量各组裸鼠肿瘤体积的变化情况。结果 抑制组的Eag1 mRNA和蛋白水平均低于空转染组和对照组,差异有统计学意义(P<0.05);与其余两组相比,抑制组的细胞增殖、克隆形成数、S期细胞比例及细胞周期蛋白水平均降低,而G0/G1期细胞比例升高,以上差异均有统计学意义(P<0.05)。抑制组裸鼠的瘤体积小于空转染组和对照组(P<0.05)。结论 通过shRNA抑制Eag1基因表达可抑制MG-63细胞的增殖并诱导G0/G1期阻滞,可能与调控cyclin D1/E通路有关,有望成为骨肉瘤治疗和诊断的新靶点。

Abstract:

Objective To explore the effects of silencing Ether-go-go 1(Eag1) potassium channel by short hairpin RNA(shRNA) on the cell proliferation, cell cycle and expression of cyclin D1/E in osteosarcoma cells. Methods The successfully constructed Ad5-Eag1-shRNA vector was transfected into MG-63 cells (inhibition group). The MG-63 cells transfected with nonsense sequence(Ad5-Control-shRNA vector) were assigned as empty transfection group and cells without any treatment was used as control group. The reverse transcription polymerase chain reaction and Western blotting were used to detect the mRNA and protein levels of Eag1 in MG-63 cells transfected with Ad5-Eag1-shRNA. Cell proliferation of each group was detected by CCK-8 assay and clone formation assay,respectively. Changes of cell cycle and protein levels of cyclin D1/E were detected by flow cytometry and Western blotting,respectively. After the establishment of osteosarcoma xenograft model in nude mice,the changes of tumor volume were measured in each group. Results The protein and mRNA levels of Eag1 were lower in inhibition group rather than empty transfection group and control group with statistically significance difference(P<0. 05). Compared with other two groups, there were decreased cell proliferation,colony formation and the proportion of cells in S phase and cell cycle protein levels but increased proportion of cells in G0/G1 phase in inhibition groups(P<0.05). The tumor volume of the inhibition group was smaller than those of the empty transfection group and the control group(P<0.05). Conclusion Eag1 silencing could suppress osteosarcoma progression and cell cycle through cyclin D1 and E pathway and suggest that Eag1 may be a novel molecular target for osteosarcoma therapy. The inhibition of Eag1 gene expression by shRNA can inhibit the proliferation and induce G0/G1 arrest,which may be related to the regulation of cyclin D1 and E pathway, and is expected to become a new target for treatment and diagnosis of osteosarcoma.

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!